State KS
Clinical Trials in Kansas
Recruiting clinical trials with at least one study location in Kansas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Kansas
NCT07420621 N/A
Recruiting
Preliminary Effectiveness of Enhanced Text Message + Incentives
Condition
Smoking Cessation
Enrollment
30 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT04832009 EARLY_Phase 1
Recruiting
Reversing Glucose and Lipid-mediated Vascular Dysfunction
Condition
Blood Pressure
Enrollment
46 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT06205121 Phase 2
Recruiting
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidos...
Condition
Pulmonary Sarcoidosis
Enrollment
96 pts
Location
United States, Denmark, France
Sponsor
Molecure S.A.
NCT06733584 N/A
Recruiting
Meeting the Needs of Young Hispanic Autistic Children
Condition
Autism
Enrollment
200 pts
Location
United States
Sponsor
The University of Texas at Dal
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06106672 Phase 1, Phase 2
Recruiting
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in S...
Condition
Myasthenia Gravis
Enrollment
54 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
NCT06959082 Phase 2
Recruiting
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy i...
Condition
Head and Neck Cancer Squamous Cell Carcinoma
Enrollment
30 pts
Location
United States
Sponsor
VSPharmTech Co.,Ltd.
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT05230459 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With...
Condition
Limb Girdle Muscular Dystrophy
Enrollment
10 pts
Location
United States
Sponsor
AskBio Inc
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
NCT06177717 N/A
Recruiting
Deep Functional Phenotyping of the ALA Lung Health Cohort
Condition
Lung Diseases
Enrollment
1,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06395753 Phase 2
Recruiting
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Condition
Prostate Cancer
Enrollment
66 pts
Location
United States, Belgium, France
Sponsor
Debiopharm International SA
NCT05561127 Phase 3
Recruiting
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Condition
Bowel; Stricture
Enrollment
171 pts
Location
United States
Sponsor
GIE Medical
NCT06045754 Phase 4
Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Usteki...
Condition
Crohn's Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Takeda
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT04864054 Phase 1, Phase 2
Recruiting
T-Cell Therapy (ECT204) in Adults With Advanced HCC
Condition
Hepatocellular Carcinoma
Enrollment
20 pts
Location
United States, Taiwan
Sponsor
Eureka Therapeutics Inc.
NCT07132411 N/A
Recruiting
Talk With Me Baby: Leveraging Well-Child Care to Enhance the Early Home Language...
Condition
Child Language
Enrollment
400 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
Page 1 of 6 — 128 trials total